Sterling Under Pressure As Election Likelihood Increases  

Published 02/09/2019, 12:06
Updated 03/08/2021, 16:15

With US markets closed for the Labour day holiday, Asia markets have had a lacklustre and negative start to September, as a raft of new and increased US and China tariffs kicked in over the weekend, with China appearing to adopt a more measured approach to escalating its countermeasures.

August was a disappointing month for equity markets, in contrast to bond markets which saw strong gains in prices as yields fell to record lows in a number of cases, with US yields in particular seeing some of their biggest monthly falls since the financial crisis, with the 10 and 30 year yields both falling by over 50bps.

This investor nervousness could well carry over into September, even though we are starting to see some signs of a pickup in some of the more recent economic data, but with gold prices and a weaker yuan likely to continue to be a dominant theme any upside for equity markets could well be limited, unless we see a significant de-escalation in tension. A lot is likely to hinge on this month’s China, US trade talks if they do take place.

In China the latest manufacturing and services PMI’s for August were somewhat mixed with a modest improvement in services, while the manufacturing surveys showed stagnation either side of 50.

Asia’s rather disappointing session stands in contrast to a positive start for Europe’s markets this morning though this could well change as we look towards Europe’s manufacturing sector where recent flash data has shown some evidence of a modest improvement, albeit from fairly low levels.

The euro slipped below the 1.1000 level last week for the first time in over two years as speculation grows that the ECB will embark on another stimulus plan when it meets in ten days’ time, against a backdrop of a weakening economic outlook, particularly in the manufacturing sector.

The latest manufacturing numbers from Spain, Italy, France and Germany has reinforced this weakness although they have improved from the July numbers, with modest improvements to 48.8, 48.7, 51.1 and 43.5 respectively.

The pound is coming under early pressure over weekend headlines that appear to suggest that a possible election could come sooner rather than later. This week has the potential to be a significant sentiment shifter if MPs succeed in passing legislation that might block a no deal Brexit, with the tug of war inside the Conservative party set to play a key part in determining how the pound fares in what is likely to be a turbulent week.

We also have the added wrinkle of a number of prorogation court cases that are set to be ruled upon in the coming days. An interim injunction has already been rejected with a full hearing tomorrow in Edinburgh to consider the merits of the case. The judge requested a formal affidavit from the PM on oath as to why he needs to suspend parliament. Another case will be heard on Thursday in a case brought by Gina Miller and joined by John Major, with the chances of success seemingly slim.

How the pound reacts to the week’s events is increasingly becoming difficult to gauge, even if the various rebels win a vote to extend article 50, beyond the 31st October. First of all the EU has to grant such a request, and secondly it’s not immediately obvious what the point of another 8 months would be able to do in unlocking the current log jam, a logjam that has paralysed UK politics for the last three years, and merely prolongs the uncertainty of stagnation into next year.

The US dollar has continued to push higher, something that is likely to displease President Trump, but something that he will find very difficult to stop even if the Federal Reserve were to do what he has asked it to do and cut rates by 100bp. The reality is the US dollar remains the best of a very sorry bunch in terms of yield and the strength of the US economy.

In company news AstraZeneca (LON:AZN) is higher after announcing results from its latest trials of its cardiovascular drug Brilinta. These showed that it reduced the risk of death and heart attack, by 10% compared with aspirin.

Marks and Spencer (LON:MKS) is also underperforming as it gets set to be relegated out of the FTSE100 in what would be the first time it has never been in the main blue chip index. Having narrowly escaped relegation in the last reshuffle its performance since then appears to have ensured it falls through the trap door since then. In a way a spell out of the spotlight may well do it some good and based on the performance of previous companies that have fallen out of the UK benchmark it hasn’t been too long before they have returned.

US markets are closed

DISCLAIMER: CMC Markets is an execution only provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed.

No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.